Search Results - "Gore, Emilia"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Transcriptomic characterization of culture-associated changes in murine and human precision-cut tissue slices by Bigaeva, Emilia, Gore, Emilia, Simon, Eric, Zwick, Matthias, Oldenburger, Anouk, de Jong, Koert P., Hofker, Hendrik S., Schlepütz, Marco, Nicklin, Paul, Boersema, Miriam, Rippmann, Jörg F., Olinga, Peter

    Published in Archives of toxicology (01-12-2019)
    “…Our knowledge of complex pathological mechanisms underlying organ fibrosis is predominantly derived from animal studies. However, relevance of animal models…”
    Get full text
    Journal Article
  2. 2

    Osteoprotegerin Expression in Liver is Induced by IL13 through TGFβ by Adhyatmika, Adhyatmika, Putri, Kurnia S S, Gore, Emilia, Mangnus, Keri A, Reker-Smit, Catharina, Schuppan, Detlef, Beljaars, Leonie, Olinga, Peter, Melgert, Barbro N

    Published in Cellular physiology and biochemistry (22-01-2022)
    “…Osteoprotegerin (OPG) is a profibrotic mediator produced by myofibro-blasts under influence of transforming growth factor β (TGFβ). Its expression in…”
    Get full text
    Journal Article
  3. 3

    Classification of Cholestatic and Necrotic Hepatotoxicants Using Transcriptomics on Human Precision-Cut Liver Slices by Vatakuti, Suresh, Pennings, Jeroen L. A, Gore, Emilia, Olinga, Peter, Groothuis, Geny M. M

    Published in Chemical research in toxicology (21-03-2016)
    “…Human toxicity screening is an important stage in the development of safe drug candidates. Hepatotoxicity is one of the major reasons for the withdrawal of…”
    Get full text
    Journal Article
  4. 4

    PI3K inhibition reduces murine and human liver fibrogenesis in precision-cut liver slices by Gore, Emilia, Bigaeva, Emilia, Oldenburger, Anouk, Kim, Yong Ook, Rippmann, Jörg F., Schuppan, Detlef, Boersema, Miriam, Olinga, Peter

    Published in Biochemical pharmacology (01-11-2019)
    “…[Display omitted] Liver fibrosis results from continuous inflammation and injury. Despite its high prevalence worldwide, no approved antifibrotic therapies…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Investigating fibrosis and inflammation in an ex vivo NASH murine model by Gore, Emilia, Bigaeva, Emilia, Oldenburger, Anouk, Jansen, Yvette J M, Schuppan, Detlef, Boersema, Miriam, Rippmann, Jörg F, Broermann, Andre, Olinga, Peter

    “…Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease, characterized by excess fat accumulation (steatosis). Nonalcoholic steatohepatitis…”
    Get more information
    Journal Article
  7. 7

    Exploring organ-specific features of fibrogenesis using murine precision-cut tissue slices by Bigaeva, Emilia, Gore, Emilia, Mutsaers, Henricus A.M., Oosterhuis, Dorenda, Kim, Yong Ook, Schuppan, Detlef, Bank, Ruud A., Boersema, Miriam, Olinga, Peter

    “…Fibrosis is the hallmark of pathologic tissue remodelling in most chronic diseases. Despite advances in our understanding of the mechanisms of fibrosis, it…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13